Related Experiment Video
Updated: Aug 8, 2026
06:14
The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
Published on: November 30, 2022
Chylous effusions revisited
Richard L. Meadows1, P. S. MacWilliams
1Department of Pathological Sciences, University of Wisconsin, 2015 Linden Drive West, Madison, WI 53706.
Veterinary Clinical Pathology
|January 1, 1994
Summary
This review clarifies milky pleural effusions in veterinary medicine, examining the differing terminology and diagnostic criteria for chylous and pseudochylous effusions. It aims to provide a more accurate understanding based on current knowledge.
Area of Science:
- Veterinary Medicine
- Comparative Pathology
Background:
- Inconsistent terminology and diagnostic criteria for milky opaque pleural effusions exist in veterinary literature.
- Previous understandings of chylous and pseudochylous effusions are being re-evaluated.
- Advances in diagnostics and pathogenesis research necessitate a review of existing concepts.
Purpose of the Study:
- To critically evaluate long-standing concepts regarding milky pleural effusions.
- To address varying terminology and diagnostic criteria in veterinary and human literature.
- To provide updated insights into the pathogenesis and differentiation of chylous and pseudochylous effusions.
Main Methods:
- Literature review and critical analysis of existing studies.
- Examination of historical and current diagnostic techniques.
- Synthesis of experimental data and pathogenetic understanding.
Main Results:
- Identified inconsistencies in the characterization of milky pleural effusions.
- Challenged established criteria for differentiating chylous from pseudochylous effusions.
- Highlighted the impact of improved understanding on effusion classification.
Conclusions:
- A unified and accurate terminology for milky pleural effusions is needed.
- Current evidence suggests a need to revise diagnostic approaches for chylous and pseudochylous effusions.
- Further research is warranted to refine understanding and management of these effusions.
Related Concept Videos
01:24Lipid Absorption
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:26Endoscopic Studies II: Thoracocentesis
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
01:19Ascites
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...